The Clinical Oncology Next Generation Sequencing Global Market Report 2021-31 by The Business Research Company describes and explains the global clinical oncology next generation sequencing market and covers 2016 to 2021, termed the historic period, and 2022 to 2026, termed the forecast period, along with further forecasts for the period 2026-2031. The report evaluates the market across each region and for the major economies within each region.
The Clinical Oncology Next Generation Sequencing Global Market Report 2022 covers clinical oncology next generation sequencing market drivers, clinical oncology next generation sequencing market trends, clinical oncology next generation sequencing market segments, clinical oncology next generation sequencing market growth rate, clinical oncology next generation sequencing market major players, and clinical oncology next generation sequencing market size.
View Complete Report:
The clinical oncology next generation sequencing market report provides in-depth analysis of the impact of COVID-19 on the global clinical oncology next generation sequencing industry along with revised market numbers due to the effects of the coronavirus and the expected clinical oncology next generation sequencing market growth numbers for 2022-2031.
The global clinical oncology next generation sequencing market size is expected to grow from $0.36 billion in 2021 to $0.39 billion in 2022 at a compound annual growth rate (CAGR) of 9.7%. The global clinical oncology NGS market share is expected to grow to $0.68 billion in 2026 at a CAGR of 14.7%.
Request Report Sample Now:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3344&type=smp
Clinical Oncology Next Generation Sequencing Global Market Report 2022 is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies. The chapter on the impact of COVID-19 gives valuable insights on supply chain disruptions, logistical challenges, and other economic implications of the virus on the market. The chapter also covers markets which have been positively affected by the pandemic.
Major Market Players
TBRC’s report covers the clinical oncology next generation sequencing market segments-
1) By Technology: Ion Semiconductor Sequencing, Pyro-Sequencing, Synthesis Sequencing, Real Time Sequencing, Ligation Sequencing, Reversible Dye Termination Sequencing, Nano-Pore Sequencing
2) By Application: Screening, Companion Diagnostics, Others
3) By End-User: Hospital Laboratories, Clinical Research Organizations, Diagnostic Laboratories
Table Of Contents
- Executive Summary
- Clinical Oncology Next Generation Sequencing Market Characteristics
- Clinical Oncology Next Generation Sequencing Market Trends And Strategies
- Impact Of COVID-19 On Clinical Oncology Next Generation Sequencing
- Clinical Oncology Next Generation Sequencing Market Size And Growth
.
.
- Africa Clinical Oncology Next Generation Sequencing Market
- Clinical Oncology Next Generation Sequencing Market Competitive Landscape And Company Profiles
- Key Mergers And Acquisitions In The Clinical Oncology Next Generation Sequencing Market
- Clinical Oncology Next Generation Sequencing Market Future Outlook and Potential Analysis
- Appendix
List Of Tables
Table 1: Global Historic Market Growth, 2016-2021, $ Billion
Table 2: Global Forecast Market Growth, 2021-2026F, 2031F, $ Billion
Table 3: Global Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 4: Global Clinical Oncology Next Generation Sequencing Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 5: Global Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
.
.
Table 46: Thermo Fisher Scientific(Qiagen) Financial Performance
Table 47: Oxford Nanopore Technologies Financial Performance
Table 48: QIAGEN Financial Performance
Table 49: Myriad Genetics Financial Performance
Table 50: Illumina Financial Performance
Related Reports
Oncology Molecular Diagnostics Global Market Report 2022
Immuno-Oncology Drugs Global Market Report 2022
Oncology Drugs Global Market Report 2022
About The Business Research Company:
The Business Research Company is a market intelligence firm that excels in company, market, and consumer research. Located globally it has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services, chemicals, and technology. It has offices in the UK, the US and India and a network of trained researchers in 20+ countries globally.
Contact Information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Find us on
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany/
Blog: http://blog.tbrc.info/
